Clinical significance of plasma levels of clomipramine, its hydroxylated and desmethylated metabolites: prediction of clinical outcome in mood disorders using discriminant analysis of therapeutic drug monitoring data
- 31 December 1993
- journal article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 29 (4) , 267-279
- https://doi.org/10.1016/0165-0327(93)90017-e
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Clinical Pharmacokinetics of ClomipramineClinical Pharmacokinetics, 1991
- Alprazolam Does Not Inhibit the Metabolism of Nortriptyline in Depressed Patients of Inhibit the Metabolism of Desipramine in Human Liver MicrosomesTherapeutic Drug Monitoring, 1988
- A Double-Blind Comparison of Dothiepin and Amitriptyline in Patients with Primary Affective Disorder: Serum Levels and Clinical ResponseThe British Journal of Psychiatry, 1980
- Pronounced inhibition of noradrenaline uptake by 10-hydroxymetabolites of nortriptylineLife Sciences, 1979
- Clinical Response and Tricyclic Plasma Levels During Treatment with ClomipramineThe British Journal of Psychiatry, 1979
- Clinical response and plasma concentration of amitriptyline and its metabolite nortriptylineEuropean Journal of Clinical Pharmacology, 1978
- A clinical trial comparing sustained release amitriptyline (Saroten® Retard) and conventional amitriptyline tablets (Saroten®) in endogenously depressed patients with simultaneous determination of serum levels of amitriptyline and nortriptylineActa Psychiatrica Scandinavica, 1978
- Nortriptyline and 10-hydroxynortriptyline plasma concentrationsJournal of Pharmacy and Pharmacology, 1976
- PLASMA-NORTRIPTYLINE LEVELS IN ENDOGENOUS DEPRESSIONThe Lancet, 1973
- Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine-like compoundsLife Sciences, 1967